Onderneming Cell MedX Corp. Other OTC
Aandelen
CMXC
US15115X1072
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Monthly Subscriptions
58,8
%
| 0 | 60,6 % | 0 | 58,8 % | -55,85% |
eBalance Devices
41,2
%
| 0 | 39,4 % | 0 | 41,2 % | -52,33% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -54,46% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 24-11-14 |
George Adams
CHM | Chairman | 76 | 23-03-18 |
Joao da Costa
BRD | Director/Board Member | 59 | 08-06-20 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27-04-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27-04-22 |
Joao da Costa
BRD | Director/Board Member | 59 | 08-06-20 |
George Adams
CHM | Chairman | 76 | 23-03-18 |
Amir Vahabzadeh
BRD | Director/Board Member | 55 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 24-11-14 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 297 236 373 | 60 447 694 ( 20,34 %) | 0 | 20,34 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,79% | 50,93 mld. | |
-0,59% | 42,12 mld. | |
+49,62% | 42,05 mld. | |
-7,20% | 29,18 mld. | |
+12,58% | 26,02 mld. | |
-21,67% | 18,9 mld. | |
+6,83% | 13,21 mld. | |
+24,96% | 12,17 mld. | |
+29,39% | 12,16 mld. |